DANIELLE DAVAROS: Open Payments
NPI 1356713648 · SAN FRANCISCO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,982 in 183 payments from 16 companies in 2025. Trend: 2023 $4,832 · 2024 $5,295 · 2025 $4,982
Food & beverage: $4,528Education: $454
| Company | Payments | Amount |
|---|---|---|
| LEO Pharma Inc. | 37 | $852 |
| Galderma Laboratories, L.P. | 17 | $558 |
| Regeneron Healthcare Solutions, Inc. | 14 | $485 |
| Janssen Biotech, Inc. | 13 | $471 |
| ABBVIE INC. | 16 | $327 |
| Lilly USA, LLC | 15 | $303 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 6 | $294 |
| GENZYME CORPORATION | 11 | $281 |
| Incyte Corporation | 13 | $275 |
| Organon LLC | 7 | $262 |
Products named: DUPIXENT, ADBRY, NEMLUVIO, TREMFYA, TALTZ, OPZELURA, VTAMA, ANZUPGO.
Industry payments across CA — which companies pay providers there.
